Thomas Stephen Basil

Track

Insider profile

Thomas Stephen Basil's trades of Climb Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
406.61
Quantity 46,560 -27.8%
Value US$3,346,892
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
408.43
Quantity 44,962 +47.5%
Value US$3,270,572
US Climb Bio Inc (CLYM)
Transaction date
Proposed sale
Price
434.12
Quantity 98,661
Value US$3,375,666
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
5.81
Quantity 10,000 -4.7%
Value US$58,141
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
5.23
Quantity 90,000 -29.5%
Value US$470,988
US Climb Bio Inc (CLYM)
Transaction date
Proposed sale
Price
5.56
Quantity 100,000
Value US$556,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-27 2026-02-26
US Climb Bio Inc (CLYM)
PlS Planned sale
46,560 -27.8%
406.61
US$3,346,892 		46,560 -27.8% 406.61 US$3,346,892
2026-02-27 2026-02-25
US Climb Bio Inc (CLYM)
PlS Planned sale
44,962 +47.5%
408.43
US$3,270,572 		44,962 +47.5% 408.43 US$3,270,572
2026-02-25 2026-02-25
US Climb Bio Inc (CLYM)
PrS Proposed sale
98,661
434.12
US$3,375,666 		98,661 434.12 US$3,375,666
2026-02-17 2026-02-13
US Climb Bio Inc (CLYM)
PlS Planned sale
10,000 -4.7%
5.81
US$58,141 		10,000 -4.7% 5.81 US$58,141
2026-02-17 2026-02-12
US Climb Bio Inc (CLYM)
PlS Planned sale
90,000 -29.5%
5.23
US$470,988 		90,000 -29.5% 5.23 US$470,988
2026-02-12 2026-02-12
US Climb Bio Inc (CLYM)
PrS Proposed sale
100,000
5.56
US$556,000 		100,000 5.56 US$556,000